Press release
Alzheimer’s drugs Market |Global Size, Share, Supply, Demand, Segments and Forecast 2020-2026
Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market, says Fortune Business Insights in a report, titled “Alzheimer’s Drugs Market Size, Share and Global Trend By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Antagonist, Combination Drugs, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast till 2026.” Rising R&D activities by pharmaceutical companies and research institutes for Alzheimer effective therapy is expected to boost the global Alzheimer’s drugs market.Highlights of the Report:
• In-depth analysis of various insights, namely, Alzheimer’s Drugs Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Alzheimer’s Drugs Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/alzheimers-drugs-market-101033
Key Players Operating in The Alzheimer’s Drugs Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Pfizer Inc.
• Eli Lilly and Company.
• Merck Sharp & Dohme Corp.
• AstraZeneca
• Biogen
• AbbVie Inc.
• ALLERGAN
Increasing R&D Investments by Pharmaceutical Companies Will Propel Growth
The active study of Alzheimer’s drug by pharmaceutical industries and research institutes for creating a strong pipeline for effective therapy is predicted to encourage growth of the global Alzheimer’s drugs market. According to the World Health Organization (WHO) currently, 50 million people are affected by dementia, and the number is expected to increase during the forecast period. In addition, the increasing cases of Alzheimer’s disease around the world have led towards high demand for Alzheimer’s drugs, which in turn is boosting the global Alzheimer’s drugs growth. However, discontinuation of clinical trials for Alzheimer’s drugs by leading pharmaceutical companies which is resulting in limited treatment options and thus creating a global economic burden by increasing the nation’s annual treatment cost against Alzheimer’s drugs development and disease treatment. This factor is predicted to hamper the growth of the global Alzheimer’s drugs market during the forecast period. For instance, Eisai and Biogen, Co., Ltd., declared the termination of phase 3 clinical trial of ENGAGE and EMERGE designed to evaluate the safety and efficacy in the treatment of Alzheimer’s disease.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/alzheimers-drugs-market-101033
Collaboration Between Eli Lilly and AC Immune Will Aid Growth
Eli Lilly and Company and AC Immune SA announced their partnership agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimer's disease (AD) and other neurodegenerative diseases. The collaboration between the two companies is predicted to benefit Alzheimer’s drugs revenue owing to the Morphomer™ platform technology which will offer commercial capabilities in central nervous system disorders along with AC Immune's lead molecule, ACI-3024. Furthermore, the development of digital tools for Alzheimer’s disease and dementia is also expected to contribute to the global Alzheimer’s drugs growth. For instance, the Alzheimer's Drug Discovery Foundation (ADDF), announced a new initiative -Diagnostics Accelerator program that aims to track the development of digital tools for Alzheimer’s disease and dementia.
Global Alzheimer’s Drugs Market Segmentation
By Drug Class
• Cholinesterase Inhibitors
• N-Methyl-D-Aspartate (NMDA) Antagonist
• Combination Drugs
• Others
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Application
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/alzheimers-drugs-market-101033
Report Focus:
• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential Alzheimer’s Drugs Market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates
Reasons to Purchase this Report:
• Comprehensive analysis of the Alzheimer’s Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:
• What is the market size and growth rate of the global and regional market by various segments?
• What is the market size and growth rate of the market for selective countries?
• Which region or sub-segment is expected to drive the market in the forecast period?
• What Factors are estimated to drive and restrain the Alzheimer’s Drugs Market growth?
• What are the key technological and market trends shaping the market?
• What are the key opportunities in the market?
• What are the key companies operating in the market?
• Which company accounted for the highest market share?
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer’s drugs Market |Global Size, Share, Supply, Demand, Segments and Forecast 2020-2026 here
News-ID: 1894014 • Views: …
More Releases from Fortune Business Insights Private Limited
![Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025-2032]](https://cdn.open-pr.com/L/5/L522889944_g.jpg)
Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025 …
Forensic Technology Market: Trends, Growth, and Key Players in 2025
Market Overview
The forensic technology market is undergoing a transformative evolution driven by advancements in AI, digitalization, and increasing global crime rates. From crime scene investigation to DNA analysis and digital forensics, modern forensic tools are revolutionizing law enforcement and judicial systems. As governments and private entities invest heavily in advanced forensic solutions, the market is poised for robust growth through 2032.…
Dental Market Size, Share, Trends & Growth Report, 2032
The global dental market size was valued at USD 37.86 billion in 2024. The market is projected to grow from USD 41.03 billion in 2025 to USD 87.65 billion by 2032, exhibiting a CAGR of 11.5% during the forecast period. North America dominated the dental market with a market share of 39.06% in 2024.
The dental market refers to the industry that encompasses all businesses, products, and services related to oral…
Contraceptives Market Growing Rapidly With a CAGR of 5.5% by 2027
🌍 Contraceptives Market: Global Industry Insights, Trends & Forecast to 2027
🤖 Market Overview
The global contraceptives market has seen consistent growth over the past decade, driven by increased awareness around reproductive health, government initiatives promoting family planning, and technological advancements in birth control methods. As we move toward 2027, the market is projected to witness significant expansion, presenting lucrative opportunities for stakeholders, manufacturers, and investors.
This article offers a comprehensive analysis of…
Smart Inhalers Market Size, Share, Growth & Industry Report (2025-2032)
🌐 Market Overview
The smart inhalers market is poised for exponential growth, driven by increasing respiratory disorders, advancements in digital health, and the demand for personalized treatment. Smart inhalers, equipped with sensors and Bluetooth technology, help patients track dosage, adherence, and treatment effectiveness in real time. These devices are increasingly integrated with mobile health apps, improving both patient outcomes and physician monitoring. With healthcare systems shifting toward remote patient management, smart…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
